Beyond the Headline: What Early ACA Rate Filings Tell Us About ICHRA in 2027
When preliminary ACA rate filings land, they tell you more than next year's premiums. They signal individual market direction, inform contribution strategy, and affect how employers should be planning right now. Here's how to read the tea leaves — and what they mean for ICHRA timing.
The first wave of 2027 individual market rate filings is starting to land, and the early numbers are giving employers, brokers, and TPAs their first real look at where pricing is headed after a turbulent year. While it’s early — only a handful of states have published preliminary filings so far — the initial data offers useful signal for anyone building ICHRA contribution strategies for the 2027 plan year.
What the Early Filings Show
As of this writing, roughly ten states have released preliminary 2027 individual market rate filings, with proposed increases ranging from approximately 6% to 22%. A few things stand out.
The range tracks the small group market. In the states that have filed so far, individual market increases are generally landing in the same range as small group filings in those same states — a sign that underlying medical trend and provider cost pressure, not ACA-specific dynamics alone, are driving a meaningful share of the increase.
Expect the range to hold, with outliers on both ends. As more states file over the coming months, we’d expect the bulk of submissions to continue falling in a similar band, with the usual handful of carriers or states landing meaningfully above or below that range — often tied to local market exits, new entrants, or state-specific risk pool dynamics.
Preliminary filings are usually directional — but this year may be different. In most years, final approved rates land close to what carriers initially file. For 2027, though, state Departments of Insurance may apply more scrutiny than usual. Regulators are increasingly looking at two-year compounded annual growth rates rather than single-year increases in isolation, especially in light of the large 2026 increases that were driven in part by the expiration of enhanced ACA premium tax credits (APTCs) and the smaller, higher-risk pool that change is expected to leave behind.
Why This Matters for ICHRA Timing
For employers and the TPAs/GAs supporting them, individual market rate movement isn’t background noise — it’s a direct input into ICHRA contribution strategy. A few ways this year’s filing cycle should inform planning.
A wider range means more dispersion across employee populations. A 6% to 22% spread — even before final approval — means the actual dollar impact of rate increases will vary significantly by geography. Employers with multi-state or multi-rating-area populations should expect meaningfully different cost trajectories for employees in different markets, with direct implications for how contribution strategies should be structured by geography or rating area.
The mulit-year view matters more than the one-year view. Looking at 2024, 2025, 2026 and 2027 increases together — rather than treating 2027 as an isolated data point — gives a more accurate picture of where individual market costs are trending and how that compares to group market alternatives. This compounded view is exactly what regulators are applying to filings, and it’s the same lens employers should use when evaluating ICHRA against fully insured or self-funded options.
What We’re Watching
Over the next several months, we’ll be tracking three things in particular: how many states see meaningful gaps between preliminary and final approved rates, whether DOI scrutiny actually translates into material rate reductions at approval, and how the eventual 2027 range compares to 2026 on a compounded basis. As more filings come in, the picture will get sharper — and we’ll keep this analysis updated as that happens.
For now, the early read is one of relative industry status rather than individual market shock: increases that are significant but largely in line with what’s happening across the broader market, with the real open question being how much regulatory scrutiny narrows the gap between what’s filed and what’s ultimately approved.
Kyndly provides an enablement layer for TPAs and GAs operating ICHRA programs — the operational infrastructure to run defined contribution health benefits at scale.